RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Clinical trial NCT04672980 · TERMINATED

Trial details

NCT number: NCT04672980
Sponsor: Rubius Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Head and Neck Cancer Anal Cancer

Start date: 2021-04-08
Primary completion: 2022-11-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.